D.E. Shaw & Co’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,859
| Closed | -$115K | – | 4540 |
|
|
2024
Q2 | $115K | Sell |
5,859
-28,204
| -83% | -$565K | ﹤0.01% | 4146 |
|
|
2024
Q1 | $872K | Buy |
+34,063
| New | +$873K | ﹤0.01% | 3179 |
|
|
2023
Q3 | – | Sell |
-1,648
| Closed | -$108K | – | 4258 |
|
|
2023
Q2 | $108K | Buy |
+1,648
| New | +$121K | ﹤0.01% | 3822 |
|
|
2023
Q1 | – | Sell |
-7,618
| Closed | -$1.05M | – | 4455 |
|
|
2022
Q4 | $1.05M | Buy |
7,618
+5,159
| +210% | +$727K | ﹤0.01% | 3408 |
|
|
2022
Q3 | $311K | Sell |
2,459
-31,289
| -93% | -$3.54M | ﹤0.01% | 4279 |
|
|
2022
Q2 | $2.79M | Buy |
33,748
+7,638
| +29% | +$592K | ﹤0.01% | 2774 |
|
|
2022
Q1 | $2.53M | Buy |
26,110
+25,013
| +2,280% | +$3.3M | ﹤0.01% | 3074 |
|
|
2021
Q4 | $219K | Sell |
1,097
-547
| -33% | -$129K | ﹤0.01% | 4831 |
|
|
2021
Q3 | $407K | Buy |
+1,644
| New | +$470K | ﹤0.01% | 4202 |
|
|
2021
Q2 | – | Sell |
-11,207
| Closed | -$4.44M | – | 4754 |
|
|
2021
Q1 | $4.38M | Sell |
11,207
-3,350
| -23% | -$1.65M | ﹤0.01% | 1949 |
|
|
2020
Q4 | $8.16M | Sell |
14,557
-8,937
| -38% | -$5.66M | 0.01% | 1502 |
|
|
2020
Q3 | $16.4M | Sell |
23,494
-988
| -4% | -$771K | 0.02% | 946 |
|
|
2020
Q2 | $19.4M | Buy |
24,482
+23,172
| +1,769% | +$17.5M | 0.02% | 797 |
|
|
2020
Q1 | $780K | Sell |
1,310
-7,916
| -86% | -$7.71M | ﹤0.01% | 2926 |
|
|
2019
Q4 | $10.5M | Buy |
9,226
+8,702
| +1,661% | +$9.46M | 0.01% | 1174 |
|
|
2019
Q3 | $623K | Buy |
524
+153
| +41% | +$234K | ﹤0.01% | 3096 |
|
|
2019
Q2 | $612K | Buy |
+371
| New | +$642K | ﹤0.01% | 2971 |
|
|
2019
Q1 | – | Sell |
-313
| Closed | -$551K | – | 3597 |
|
|
2018
Q4 | $402K | Sell |
313
-392
| -56% | -$601K | ﹤0.01% | 3210 |
|
|
2018
Q3 | $1.33M | Buy |
+705
| New | +$1.46M | ﹤0.01% | 2489 |
|
|
2018
Q2 | – | Sell |
-487
| Closed | -$1.11M | – | 3697 |
|
|
2018
Q1 | $1.08M | Sell |
487
-8,165
| -94% | -$20.8M | ﹤0.01% | 2442 |
|
|
2017
Q4 | $20M | Buy |
8,652
+1,851
| +27% | +$3.76M | 0.03% | 684 |
|
|
2017
Q3 | $12.1M | Buy |
6,801
+4,250
| +167% | +$5.94M | 0.02% | 829 |
|
|
2017
Q2 | $3.47M | Buy |
2,551
+1,518
| +147% | +$1.83M | 0.01% | 1606 |
|
|
2017
Q1 | $1.22M | Buy |
+1,033
| New | +$1.05M | ﹤0.01% | 2176 |
|
|
2016
Q4 | – | Sell |
-1,389
| Closed | -$1.1M | – | 3436 |
|
|
2016
Q3 | $1.22M | Buy |
+1,389
| New | +$1.01M | ﹤0.01% | 2270 |
|
|
2015
Q4 | – | Sell |
-391
| Closed | -$391K | – | 3791 |
|
|
2015
Q3 | $433K | Sell |
391
-1,668
| -81% | -$3.04M | ﹤0.01% | 3150 |
|
|
2015
Q2 | $4.49M | Sell |
2,059
-135
| -6% | -$275K | 0.01% | 1553 |
|
|
2015
Q1 | $3.43M | Buy |
2,194
+463
| +27% | +$611K | 0.01% | 1643 |
|
|
2014
Q4 | $2.06M | Buy |
+1,731
| New | +$1.16M | ﹤0.01% | 2261 |
|
Other funds holding BLUE
APM
LPC
D.E. Shaw & Co's BLUE Position: Q3 2024 in Review
D.E. Shaw & Co sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 5,859 shares — an estimated $115K sold.
D.E. Shaw & Co first reported a position in BLUE in Q4 2014 and held it in 29 quarters. The position peaked at $20M in Q4 2017. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.
- D.E. Shaw & Co reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
- D.E. Shaw & Co sold 5,859 bluebird bio shares in Q3 2024, an estimated $115K.
- D.E. Shaw & Co first reported a position in bluebird bio in Q4 2014 and held it in 29 quarters.
- D.E. Shaw & Co's bluebird bio position peaked at $20M in Q4 2017.
- 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.